149 related articles for article (PubMed ID: 8698314)
1. The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin.
Staibano S; Boscaino A; Salvatore G; Orabona P; Palombini L; De Rosa G
Hum Pathol; 1996 Jul; 27(7):695-700. PubMed ID: 8698314
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of apoptotic index in cutaneous basal cell carcinomas of head and neck.
Staibano S; Lo Muzio L; Mezza E; Argenziano G; Tornillo L; Pannone G; De Rosa G
Oral Oncol; 1999 Nov; 35(6):541-7. PubMed ID: 10705087
[TBL] [Abstract][Full Text] [Related]
3. p53 protein in aggressive and non-aggressive basal cell carcinoma.
De Rosa G; Staibano S; Barra E; Donofrio V; Salvatore G; Vessecchia G; Boscaino A
J Cutan Pathol; 1993 Oct; 20(5):429-34. PubMed ID: 7507946
[TBL] [Abstract][Full Text] [Related]
4. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
5. Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck.
Staibano S; Lo Muzio L; Pannone G; Scalvenzi M; Salvatore G; Errico ME; Fanali S; De Rosa G; Piattelli A
Anticancer Res; 2001; 21(6A):3757-64. PubMed ID: 11911244
[TBL] [Abstract][Full Text] [Related]
6. P53 and hMSH2 expression in basal cell carcinomas and malignant melanomas from photoexposed areas of head and neck region.
Staibano S; Lo Muzio L; Pannone G; Somma P; Farronato G; Franco R; Bambini F; Serpico R; De Rosa G
Int J Oncol; 2001 Sep; 19(3):551-9. PubMed ID: 11494035
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients.
Mackenzie KA; Miller AP; Hock BD; Gardner J; Simcock JW; Roake JA; Dachs GU; Robinson BA; Currie MJ
Histopathology; 2011 May; 58(6):875-85. PubMed ID: 21585427
[TBL] [Abstract][Full Text] [Related]
8. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway.
Chu CY; Cha ST; Lin WC; Lu PH; Tan CT; Chang CC; Lin BR; Jee SH; Kuo ML
Carcinogenesis; 2009 Feb; 30(2):205-13. PubMed ID: 18849299
[TBL] [Abstract][Full Text] [Related]
9. Differences in the vascular patterns of basal and squamous cell skin carcinomas explain their differences in clinical behaviour.
Chin CW; Foss AJ; Stevens A; Lowe J
J Pathol; 2003 Jul; 200(3):308-13. PubMed ID: 12845626
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Immunohistochemical Findings and Clinical Features Associated with Local Aggressiveness in Basal Cell Carcinoma.
ShamsiMeymandi S; Dabiri S; ZeynadiniMeymand A; Iranpour M; Khalili M; Alijani S; Aflatoonian M
Iran J Pathol; 2019; 14(3):193-196. PubMed ID: 31582995
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck.
Staibano S; Lo Muzio L; Pannone G; Mezza E; Argenziano G; Vetrani A; Lucariello A; Franco R; Errico ME; De Rosa G;
Am J Clin Pathol; 2001 Jun; 115(6):805-13. PubMed ID: 11392875
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
Bartoš V; Kullová M
Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
[TBL] [Abstract][Full Text] [Related]
13. CD34 microvessel density and VEGF expression in basal and squamous cell carcinoma.
Loggini B; Boldrini L; Gisfredi S; Ursino S; Camacci T; De Jeso K; Cervadoro G; Pingitore R; Barachini P; Leocata P; Fontanini G
Pathol Res Pract; 2003; 199(11):705-12. PubMed ID: 14708636
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar organizer regions in aggressive and nonaggressive basal cell carcinoma of the skin.
De Rosa G; Staibano S; Barra E; Zeppa P; Salvatore G; Vetrani A; Palombini L
Cancer; 1992 Jan; 69(1):123-6. PubMed ID: 1727656
[TBL] [Abstract][Full Text] [Related]
15. Trisomy 6 in basal cell carcinomas correlates with metastatic potential: a dual color fluorescence in situ hybridization study on paraffin sections.
Nangia R; Sait SN; Block AW; Zhang PJ
Cancer; 2001 May; 91(10):1927-32. PubMed ID: 11346875
[TBL] [Abstract][Full Text] [Related]
16. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
17. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
Bartoš V; Kullová M
Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
[TBL] [Abstract][Full Text] [Related]
18. Microvessel density and VEGF expression seems to correlate with invasiveness of basal cell carcinoma.
Carbone A; Viola P; Varrati S; Angelucci D; Tulli A; Amerio P
Eur J Dermatol; 2011; 21(4):608-9. PubMed ID: 21865111
[No Abstract] [Full Text] [Related]
19. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
[TBL] [Abstract][Full Text] [Related]
20. Molecular signatures linked with aggressive behavior in basal cell carcinoma: a report of 6 cases.
Fernandes H; Fernandes N; Bhattacharya S; Chen W; Seth A; Hameed M; Mirani N; Lambert WC
Am J Dermatopathol; 2010 Aug; 32(6):550-6. PubMed ID: 20489570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
